From the Population Research Center, University of Texas at Austin, Austin, Texas; the Department of Languages and Linguistics, University of Texas at El Paso, El Paso, Texas; the College of Nursing, New York University, New York, New York; and Ibis Reproductive Health, Oakland, California.
Obstet Gynecol. 2011 Mar;117(3):551-557. doi: 10.1097/AOG.0b013e31820afc46.
To estimate differences in continuation of oral contraceptive pills (OCPs) between U.S. resident women obtaining pills in U.S. family planning clinics compared with over-the-counter in Mexican pharmacies.
In El Paso, Texas, we recruited 514 OCP users who obtained pills over the counter from a Mexican pharmacy and 532 who obtained OCPs by prescription from a family planning clinic in El Paso. A baseline interview was followed by three consecutive surveys over 9 months. We asked about date of last supply, number of pill packs obtained, how long they planned to continue use, and experience of side effects. Retention was 90%, with only 105 women lost to follow-up.
In a multivariable Cox proportional hazards model, discontinuation was higher for women who obtained pills in El Paso clinics compared with those who obtained their pills without a prescription in Mexico (hazard ratio 1.6, 95% confidence interval [CI] 1.1-2.3). Considering the number of pill packs dispensed to clinic users, discontinuation rates were higher (hazard ratio 1.8, 95% CI 1.2-2.7) for clinic users who received one to five pill packs. However, there was no difference in discontinuation between clinic users receiving six or more pill packs and users obtaining pills without a prescription.
Results suggest providing OCP users with more pill packs and removing the prescription requirement would lead to increased continuation.
评估与在美国家庭计划诊所通过处方获取口服避孕药相比,美国居民女性在墨西哥药店购买非处方避孕药的续用率差异。
在德克萨斯州的埃尔帕索,我们招募了 514 名从墨西哥药店购买非处方避孕药的使用者和 532 名从埃尔帕索家庭计划诊所通过处方获取避孕药的使用者。在基线访谈后,我们在 9 个月内进行了三次连续调查。我们询问了最后一次供应的日期、获得的药丸包数、计划继续使用的时间以及副作用的经历。保留率为 90%,只有 105 名女性失访。
在多变量 Cox 比例风险模型中,与在墨西哥无需处方获取药丸的女性相比,在埃尔帕索诊所获取药丸的女性停药率更高(风险比 1.6,95%置信区间 [CI] 1.1-2.3)。考虑到分配给诊所使用者的药丸包数,接受 1-5 个药丸包的诊所使用者的停药率更高(风险比 1.8,95% CI 1.2-2.7)。然而,接受 6 个或更多药丸包的诊所使用者和无需处方获取药丸的使用者之间的停药率没有差异。
结果表明,为口服避孕药使用者提供更多的药丸包并取消处方要求将导致续用率增加。